摘要
目的 观察注射用血凝酶（巴曲亭）在脑外伤围手术期的应用效果以及对凝血功能的影响.方法 60例脑外伤手术患者,ASA Ⅰ～Ⅲ级,完全随机分为观察组和对照组,各30例.观察组术前30 min肌内注射1 U注射用血凝酶,手术开始后静脉滴注注射用血凝酶2 U至术毕.对照组于手术开始后静脉滴注氨基氨甲环酸0.25 g至术毕.比较2组患者的术中出血量、术后24 h引流量和输血量,并检测术前及术终凝血酶原时间（PT）、部分凝血活酶时间对照APTT、凝血酶时间（TT）、纤维蛋白原（FIB）定量和PLT计数,常规术后随访1周.结果 观察组术中出血量、术后24 h引流量以及输血量明显少于对照组[（780±90）ml比（1150±150）ml,（120±15）ml比（155±18）ml,（600±50）ml比（900±60）ml,均P＜0.01];2组FIB及PLT均减少,但观察组凝血状态未发生明显变化,对照组APTT、TT、PT均明显高于术前[（26.7±3.5）s比（22.5±2.0）s,（14.2±2.1）s比（12.1±1.3）s,（15.0±1.4）s比（11.9±1.2）s,P＜0.01].2组患者术后1周均未发生脑血栓.结论 注射用血凝酶用于脑外伤手术可以明显减少出血量及输血量,并且能局部应用,不影响患者凝血功能,不会增加血栓形成的危险.
Objective To explore the hemostatic effect and influence on coagulation function of hemocoagulase during cerebral trauma operation. Methods Sixty patients ASA Ⅰ -Ⅲ with cerebral trauma were randomly divided into two groups： hemocoagulase treatment group（n=30） and tranexamic acid treatment group（n=30）. The volume of bleeding during the operation and the volume of postoperative 24-hour drainage and transfusion of blood were recorded in all the patients. Prothrombin time（PT）, activated partial thromboplastin time（APTT）, thromin time（TT）, fibrinogen level and blood platelet counts before and after the surgery were also determined. All the patients were postoperatively followed up for 1 week. Results The volume of bleeding during the surgery and the volume of postoperative 24-hour drainage and transfusion of blood in the hemocoagulase treatment group were significantly fewer than the tranexamic acid treatment group [（780 ±90） ml vs （1150 ± 150） ml, （120 ± 15） ml vs （155 ± 18） ml, （600 ±50） ml vs （900 ± 60） ml, P〈0.01]. The levels of fibrinogen and blood platelet significantly decreased after the surgery in both of the groups compare to preoperation （P〈0.05）. After the operation the insignificant changes in the coagulation function were observed in hemocoagulase treatment group compared to the preoperation, whereas the APTT, TT, PT in carbenzamine treatment group were significantly higher after the surgery than those before the surgery[（26.7±3.5）s vs （22.5 ±2.0）s, （14. 2 ±2.1）s vs （12.1 ±1.3）s, （15.0 ± 1.4）s vs （11.9 ±1.2）s, P〈0.01]. The cerebral thrombosis did not occurred within 1 week after the operation in all the patients of both the groups. Conclusions Hemocoagulase treatment during the operation for cerebral trauma can reduce the volume of bleeding and transfusion of blood, and did not affect the coagulation function in the patients. Therefore, hemocoagulase can be used as a safe and effective hemostatic during the op
出处
《中国医药》
2011年第8期955-956,共2页
China Medicine
关键词
颅脑损伤
注射用血凝酶
凝血功能
Cramiocerebral trauma
Hemocoagulase
Coagulation function
